UNSPSC 85492915: Revision of autologous tissue substitute in heart, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in heart, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02WA47Z

UNSPSC 85492915, Revision of autologous tissue substitute in heart, percutaneous endoscopic approach, is a Commodity code that shows little relevant recent state and local procurement activity. The code describes a specific cardiac surgical procedure, yet the recent opportunities tagged to it do not align with that scope. The City of Phoenix Retirement Office is soliciting independent medical evaluation services for disability determinations; the City of Long Beach is seeking a surgical benefit carve-out program for a PPO plan that offers selected procedures including heart surgery through Centers of Excellence; the Washington State Department of Transportation is requesting occupational medical surveillance services; Harris County Juvenile Probation Department is issuing an RFI for emergency and specialty medical services for detained youth; Collier County is procuring pharmacy benefit management services; and the County of Santa Clara Health System is establishing a qualified vendor pool for temporary health professional staffing across ancillary clinical specialties. None of these solicitations target the procurement or revision of autologous tissue substitutes for cardiac procedures. The mismatch between the code's nominal scope and the actual work being bought suggests that state and local procurement offices are applying this code inconsistently or that these records reflect data classification errors rather than genuine opportunities under the code's intended category.

State and local buyers in Arizona, California, Florida, and Washington have posted recent activity, but the opportunities are concentrated in administrative health services (medical record review, benefit management, occupational health screening, and staffing augmentation) rather than in cardiac surgical products or tissue substitutes. The geographic spread spans the Southwest and Pacific regions, with no evident concentration in any single state. Until state and local solicitations that genuinely target autologous cardiac tissue products or procedures appear in the marketplace, the code shows no actionable procurement signal for firms seeking to pursue business in this product or service line.